Phibro Animal Health (NASDAQ:PAHC) Hits New 1-Year High - What's Next?

Key Points

• Phibro Animal Health's stock reached a new 52-week high of $32.95, closing last at $32.31 with a trading volume of 194,402 shares.
• Analysts have raised their price targets for the stock, with JPMorgan Chase increasing its target from $25.00 to $35.00 and proposing an "overweight" rating.
• The company announced a quarterly dividend of $0.12 per share, with a yield of 1.5%, reflecting a payout ratio of 61.54%.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report)'s stock price reached a new 52-week high during trading on Monday . The company traded as high as $32.95 and last traded at $32.31, with a volume of 194402 shares. The stock had previously closed at $31.55.

Analysts Set New Price Targets

A number of research analysts have commented on PAHC shares. JPMorgan Chase & Co. raised Phibro Animal Health from a "neutral" rating to an "overweight" rating and increased their target price for the stock from $25.00 to $35.00 in a report on Monday, July 7th. Morgan Stanley set a $26.00 target price on Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th. BNP Paribas raised Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. BNP Paribas Exane raised Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price on the stock in a report on Monday, June 16th. Finally, Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average price target of $24.40.

Phibro Animal Health Stock Down 0.8%

The firm has a 50 day simple moving average of $28.31 and a two-hundred day simple moving average of $24.12. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91. The stock has a market cap of $1.30 billion, a P/E ratio of 41.28, a P/E/G ratio of 0.54 and a beta of 0.80.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a yield of 1.5%. Phibro Animal Health's payout ratio is presently 61.54%.

Institutional Trading of Phibro Animal Health

Several hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in shares of Phibro Animal Health by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock worth $32,500,000 after buying an additional 6,784 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Phibro Animal Health by 0.5% in the 1st quarter. Acadian Asset Management LLC now owns 782,939 shares of the company's stock worth $16,713,000 after buying an additional 4,144 shares in the last quarter. Nuveen Asset Management LLC raised its stake in shares of Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after buying an additional 103,618 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Phibro Animal Health by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 554,927 shares of the company's stock worth $14,175,000 after buying an additional 7,841 shares in the last quarter. Finally, Nuveen LLC bought a new stake in shares of Phibro Animal Health in the 1st quarter worth $10,312,000. Institutional investors own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.